EI

259.5

-1.48%↓

SAN

84.4

-1.16%↓

MRK1

108.7

+0.83%↑

SHL.DE

47.28

0%↓

ARGX

603.4

+0.2%↑

EI

259.5

-1.48%↓

SAN

84.4

-1.16%↓

MRK1

108.7

+0.83%↑

SHL.DE

47.28

0%↓

ARGX

603.4

+0.2%↑

EI

259.5

-1.48%↓

SAN

84.4

-1.16%↓

MRK1

108.7

+0.83%↑

SHL.DE

47.28

0%↓

ARGX

603.4

+0.2%↑

EI

259.5

-1.48%↓

SAN

84.4

-1.16%↓

MRK1

108.7

+0.83%↑

SHL.DE

47.28

0%↓

ARGX

603.4

+0.2%↑

EI

259.5

-1.48%↓

SAN

84.4

-1.16%↓

MRK1

108.7

+0.83%↑

SHL.DE

47.28

0%↓

ARGX

603.4

+0.2%↑

Search

Orion Oyj (Class B)

Closed

68.2 -0.37

Overview

Share price change

24h

Current

Min

67.9

Max

68.8

Key metrics

By Trading Economics

Income

119M

180M

Sales

62M

417M

P/E

Sector Avg

25.781

35.724

EPS

0.59

Dividend yield

2.36

Profit margin

43.289

Employees

3,700

EBITDA

202M

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.36%

3.09%

Market Stats

By TradingEconomics

Market Cap

875M

9.8B

Previous open

68.57

Previous close

68.2

Orion Oyj (Class B) Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 sie 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 sie 2025, 23:48 UTC

Market Talk

Nikkei May Trade Rangebound; Data in Focus -- Market Talk

28 sie 2025, 22:48 UTC

Market Talk

Eagers Automotive's Valuation Too High for Jefferies -- Market Talk

28 sie 2025, 22:35 UTC

Earnings

Capricorn Metals Net Cash A$355.8 Million at June 30

28 sie 2025, 22:35 UTC

Earnings

Capricorn Metals: Focused on Goal of Becoming Multi-mine, Mid-tier Gold Miner

28 sie 2025, 22:35 UTC

Earnings

Capricorn Metals: Expects 'Another Strong Year' in FY26 for Karlawinda Gold Project

28 sie 2025, 22:34 UTC

Earnings

Capricorn Metals FY Revenue A$505.9 Million, Up 41% On-Year

28 sie 2025, 22:33 UTC

Earnings

Capricorn Metals FY Ebitda A$273.4 Million, Up 62% On-Year

28 sie 2025, 22:33 UTC

Earnings

Capricorn Metals FY Profit Before Tax A$217.8 Million, Up 73% On-Year

28 sie 2025, 22:32 UTC

Earnings

Capricorn Metals FY Net Profit A$150.3 Million, Up 72% On-Year

28 sie 2025, 22:15 UTC

Earnings

Sayona Cash Balance A$72 Million at June 30

28 sie 2025, 22:14 UTC

Earnings

Sayona FY Underlying Ebitda Loss A$67 Million

28 sie 2025, 22:11 UTC

Earnings

Gold Road Resources Says Won't Pay an Interim Dividend

28 sie 2025, 22:11 UTC

Earnings

Gold Road Resources 1H Ebitda A$201.8 Million, Roughly Doubles on Year

28 sie 2025, 22:10 UTC

Earnings

Gold Road Resources 1H Revenue A$349.2 Million, Up 65% on Year

28 sie 2025, 22:10 UTC

Earnings

Gold Road Resources 1H Net Profit A$107 Million, More Than Doubles

28 sie 2025, 22:03 UTC

Earnings

Affirm Stock Rises 13% After Earnings. What Has Wall Street Excited. -- Barrons.com

28 sie 2025, 21:54 UTC

Market Talk

Caterpillar Raises Its Forecasted Tariff Expense -- Market Talk

28 sie 2025, 21:54 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

28 sie 2025, 20:58 UTC

Earnings

Gap Stock Falls Despite Earnings Beat. Tariffs May Hurt. -- Barrons.com

28 sie 2025, 20:58 UTC

Earnings

S&P 500, Dow Industrials Notch Records After GDP Revision -- WSJ

28 sie 2025, 20:50 UTC

Earnings

Dell Beat Earnings Estimates. Why the Stock Is Down. -- Barrons.com

28 sie 2025, 20:30 UTC

Earnings

Alibaba Earnings Are Coming. AI, Price Wars, and Tariffs Could Leave Their Mark. -- Barrons.com

28 sie 2025, 20:28 UTC

Earnings

Dell Beat Earnings Estimates. Why the Stock Is Down. -- Barrons.com

28 sie 2025, 20:22 UTC

Earnings

Nvidia Earnings Disappointed. GE Vernova and 5 More Industrial Stocks Get a Boost. -- Barrons.com

28 sie 2025, 20:19 UTC

Earnings

Dell Beat Earnings Estimates. Why the Stock Is Down. -- Barrons.com

28 sie 2025, 20:17 UTC

Earnings

Li Auto Stock Rises and Falls. How China's EV Price War Dented Earnings. -- Barrons.com

28 sie 2025, 20:07 UTC

Earnings

IREN 4Q Rev $187.3M >IREN

28 sie 2025, 19:23 UTC

Market Talk

Oil Futures Stage Late Turnaround -- Market Talk

28 sie 2025, 19:11 UTC

Acquisitions, Mergers, Takeovers

Trump Fires Rail Regulator. Investors Are Taking Note. -- Barrons.com

Peer Comparison

Price change

Orion Oyj (Class B) Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.